SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,217,822 | +7.4% | 92,541 | +1.5% | 0.00% | +33.3% |
| Q2 2023 | $10,441,592 | -24.1% | 91,177 | -8.6% | 0.00% | -40.0% |
| Q1 2023 | $13,755,985 | +31.0% | 99,804 | +23.1% | 0.01% | +25.0% |
| Q4 2022 | $10,502,072 | +21.9% | 81,047 | +4.0% | 0.00% | +33.3% |
| Q3 2022 | $8,615,000 | +25.0% | 77,934 | -15.3% | 0.00% | +50.0% |
| Q2 2022 | $6,893,000 | -3.9% | 91,961 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $7,176,000 | -8.4% | 91,851 | +5.5% | 0.00% | 0.0% |
| Q4 2021 | $7,838,000 | -1.7% | 87,035 | +1.0% | 0.00% | -33.3% |
| Q3 2021 | $7,970,000 | -54.7% | 86,178 | -62.0% | 0.00% | -50.0% |
| Q2 2021 | $17,608,000 | -42.8% | 226,493 | -45.2% | 0.01% | -45.5% |
| Q1 2021 | $30,807,000 | -55.5% | 413,363 | +1.7% | 0.01% | -59.3% |
| Q4 2020 | $69,280,000 | +20.7% | 406,356 | -0.6% | 0.03% | +3.8% |
| Q3 2020 | $57,385,000 | +36.4% | 408,631 | +55.7% | 0.03% | +30.0% |
| Q2 2020 | $42,074,000 | +70.8% | 262,412 | +4.5% | 0.02% | +42.9% |
| Q1 2020 | $24,636,000 | -17.0% | 251,148 | +9.2% | 0.01% | 0.0% |
| Q4 2019 | $29,666,000 | +120.3% | 229,897 | +28.6% | 0.01% | +100.0% |
| Q3 2019 | $13,469,000 | +127.4% | 178,821 | +358.7% | 0.01% | +133.3% |
| Q2 2019 | $5,924,000 | +32.8% | 38,985 | +4.2% | 0.00% | 0.0% |
| Q1 2019 | $4,462,000 | +16.4% | 37,431 | +6.6% | 0.00% | 0.0% |
| Q4 2018 | $3,832,000 | -18.9% | 35,117 | +20.1% | 0.00% | 0.0% |
| Q3 2018 | $4,723,000 | +26.9% | 29,239 | +3.8% | 0.00% | 0.0% |
| Q2 2018 | $3,723,000 | +100.4% | 28,165 | +12.3% | 0.00% | +200.0% |
| Q1 2018 | $1,858,000 | +26.4% | 25,080 | -4.9% | 0.00% | 0.0% |
| Q4 2017 | $1,470,000 | +31.6% | 26,363 | +8.1% | 0.00% | 0.0% |
| Q3 2017 | $1,117,000 | +88.4% | 24,396 | +38.7% | 0.00% | – |
| Q2 2017 | $593,000 | +19.1% | 17,590 | +3.9% | 0.00% | – |
| Q1 2017 | $498,000 | +5.7% | 16,927 | -1.3% | 0.00% | – |
| Q4 2016 | $471,000 | -16.9% | 17,149 | +83.4% | 0.00% | -100.0% |
| Q3 2016 | $567,000 | +329.5% | 9,353 | +30.0% | 0.00% | – |
| Q2 2016 | $132,000 | -8.3% | 7,192 | 0.0% | 0.00% | – |
| Q1 2016 | $144,000 | -50.0% | 7,192 | -2.6% | 0.00% | – |
| Q4 2015 | $288,000 | +24.7% | 7,382 | 0.0% | 0.00% | – |
| Q3 2015 | $231,000 | +7.4% | 7,382 | 0.0% | 0.00% | – |
| Q2 2015 | $215,000 | +162.2% | 7,382 | +23.8% | 0.00% | – |
| Q1 2015 | $82,000 | -5.7% | 5,965 | 0.0% | 0.00% | – |
| Q4 2014 | $87,000 | -31.0% | 5,965 | 0.0% | 0.00% | – |
| Q3 2014 | $126,000 | – | 5,965 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |